{"title":"89P Safety and efficacy of rechallenge with immune checkpoint inhibitors in advanced solid tumor: A systematic review and meta-analysis","authors":"H.J. Xu","doi":"10.1016/j.iotech.2024.100832","DOIUrl":"10.1016/j.iotech.2024.100832","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100832"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143133457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
R. Coelho , C. Schliehe , E. Shifrut , R. Debets , D. Hammerl
{"title":"64P Gene-editing of T cells to provide resistance against macrophage-mediated suppression: Setting up an in vitro model","authors":"R. Coelho , C. Schliehe , E. Shifrut , R. Debets , D. Hammerl","doi":"10.1016/j.iotech.2024.100875","DOIUrl":"10.1016/j.iotech.2024.100875","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100875"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143134579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
J. Blanc , N. Martinez Chanza , A. Carnot , P. Barthelemy , N. Kotecki , M. Maetens , G. Dosin , A.H. Awada , D. Venet , C. Sotiriou , S. Rorive , F. Rothé
{"title":"29P Prognostic value of systemic inflammatory index and platelet-to-lymphocyte ratio in muscle-invasive bladder cancer patients treated with neoadjuvant chemo-immunotherapy in the AURA trial","authors":"J. Blanc , N. Martinez Chanza , A. Carnot , P. Barthelemy , N. Kotecki , M. Maetens , G. Dosin , A.H. Awada , D. Venet , C. Sotiriou , S. Rorive , F. Rothé","doi":"10.1016/j.iotech.2024.100911","DOIUrl":"10.1016/j.iotech.2024.100911","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100911"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143140277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
L. Soumoy , V. Quidville , C. Sarre-Pradon , L. Lacroix , E. Routier , H. Hermann , S. Roy , N. Benannoune , S. Vagner , F. Chehade , B. Archambaud , C. Robert
{"title":"3MO LDH isoforms shape the immune microenvironment and impact treatment response and survival in metastatic melanoma","authors":"L. Soumoy , V. Quidville , C. Sarre-Pradon , L. Lacroix , E. Routier , H. Hermann , S. Roy , N. Benannoune , S. Vagner , F. Chehade , B. Archambaud , C. Robert","doi":"10.1016/j.iotech.2024.100887","DOIUrl":"10.1016/j.iotech.2024.100887","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100887"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143177778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M. Mangolini , S. Srivastava , E. Souster , Y. Yang , R. Karatill , L. Schultz , B. Ma , D. Pombal , A. Ramon , M. Greenig , P. Sormanni , S. Cordoba , S. Onuoha
{"title":"49P Highly potent novel armoured IL13Ra2 CAR T cell targeting glioblastoma","authors":"M. Mangolini , S. Srivastava , E. Souster , Y. Yang , R. Karatill , L. Schultz , B. Ma , D. Pombal , A. Ramon , M. Greenig , P. Sormanni , S. Cordoba , S. Onuoha","doi":"10.1016/j.iotech.2024.100860","DOIUrl":"10.1016/j.iotech.2024.100860","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100860"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143129092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}